T-cell epitope mapping by flow cytometry

Nature Medicine

Volumn 4, Issue 8, 1998, Pages 975-976

  Kern, Florian ^a   Surel, Ingolf Pascal ^a   Brock, Carsten ^a   Freistedt, Bernd ^a   Radtke, Hartmut ^a   Scheffold, Alexander ^b   Blasczyk, Rainer ^a   Reinke, Petra ^a   Schneider Mergener, Jens ^a   Radbruch, Andreas ^b   Walden, Peter ^a   Volk, Hans Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON;

AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; CYTOKINE RELEASE; EPITOPE MAPPING; FLOW CYTOMETRY; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

AMINO ACID SEQUENCE; EPITOPE MAPPING; EPITOPES; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HLA-B7 ANTIGEN; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031926797     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0898-975     Document Type: Review

References (14)

1. Moss, P.A. et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. USA 92, 5773-5777 (1995).
2. Borysiewicz, L.K. et al. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med. 168, 919-931 (1988).
3. Gross, H.J., Verwer, B., Houck, D. & Recktenwald, D. Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry 14, 519-526 (1993).
4. Radbruch, A. & Recktenwald, D. Detection and isolation of rare cells. Curr. Opin. Immunol. 7, 270-273 (1995).
5. + T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99, 1739-1750 (1997).
6. Wills, M.R. et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70, 7569-7579 (1996).
7. Rammensee, H.G., Friede, T. & Stefanovic, S. MHC ligands and peptide motifs: First listing. Immunogenetics 41, 178-228 (1995).
8. Diamond, D.J., York, J., Sun, J.Y., Wright, C.L. & Forman, S.J. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90, 1751-1767 (1997).
9. Parker, K.C., Bednarek, M.A. & Coligan, J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152, 163-175 (1996).
10. Sherman, L.A., Burke, T.A. & Biggs, J.A. Extracellular processing of peptide antigens that bind class I major histocompatibility molecules. J. Exp. Med. 175, 1221-1226 (1992).
11. Rammensee, H.G., Bachmann, J., & Stevanovic, S. in. MHC Ligands and Peptide Motifs. (Landes Bioscience, Georgetown, Texas, 1997).
12. Brusic, V., Rudy, G., Harrison, L.C. MHCPEP, a database of MHC-binding peptides: Update 1997. Nucleic Acids Res. 26, 370-373 (1998).
13. Roederer, M. et al. 8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. Cytometry 29, 328-339 (1997).
14. Assenmacher, M. et al. Specific expression of surface interferon-gamma on interferon-gamma producing T cells from mouse and man. Eur. J. Immunol. 26, 263-267 (1996).